Skip to main content
. 2022 Jan 21;15(2):128. doi: 10.3390/ph15020128

Table 4.

Bibliographic data of the cited patents/patent applications.

Patent/Patent Application Number
(Assignee; Publication Date; Priority Country; Estimated Expiry Date)
Legal Status on 6 November 2021
(International Patent Classification)
Family Members on 6 November 2021
US4042705A
(Hoechst AG; August 16, 1977; Germany; Expired)
Expired patent
(A61K31/415, A61P31/04, C07D233/94, (IPC1-7): A61K31/415, C07D233/94)
AT359059B, AU500640B2, CH605813A5, CH605819A5, DK142412C, EG12284A, ES449589A1, FI61185C, FR2317925B1, GB1541280A, GR66090B, HU173463B, IE43692B1, IL50023A, IT1064924B, JPS5231074A, LU75359A1, MX3539E, MY8100120A, NL7607495A, NO145136B, NO145136C, NZ181421A, PT65350B, SE414927B
CA1079738A
(Hoechst AG; 17 June 1980; Germany; Expired)
Expired patent
(C07D233/94, (IPC1-7): C07D233/94)
AT361468B, ATA128477A, CH624942A5, DK144524C, EG13828A, ES456117A2, FI770599A, IT1115608B, LU76834A1, NL7701838A, NO770648L, SE7702126L
US9758488B2
(Sanofi; 12 September 2017; Europe; 24 December 2032)
Patented case
(C07D233/94)
AP3759A, BR112015011446A2, CA2892334C, CN104797562B, CR20150286A, CY1118983T1, ECSP15025960A, EP2922822B1, ES2618800T3, HRP20170390T1, HUE032160T2, IL238934A, MX365587B, PL2922822T3, SG11201504047TA, SI2922822T1, WO2014079497A1, ZA201503063B
US9585871B2
(Merial Limited; 7 March 2017; USA; 31 January 2034)
Patented case
(A61K31/4164)
AU2014212217B2, CY1120381T1, DK2950795T3, EP2950795B1, ES2681420T3, HK1211466A1, HRP20181181T1, HUE039467T2, IL240246A, LT2950795T, MX367952B, PL2950795T3, PT2950795T, RS57469B1, SI2950795T1, WO2014121064A1
WO9912547A1
(Theramark Limited; 18 March 1999; United Kingdom; 8 September 2018)
Lapsed
(A61K31/404, A61K31/407, A61K31/4155, A61K31/4174, A61K31/535, (IPC1-7): A61K31/40, A61K31/41, A61K31/415, A61K31/535)
AU9082698A, AU9082798A
WO9912548A1
(Theramark Limited; 18 March 1999; United Kingdom; 8 September 2018)
US2021220335A1
(IRP Health Pty Ltd.; 22 July 2021; Australia; 29 May 2039)
Under examination
(A23K20/121, A23K20/137, A23K20/195, A23K50/30, A23L33/00, A23L33/10, A61K31/4164, A61K31/4375, A61K9/00, A61P31/04)
AU2019277198A1, CN112543635A, EP3810137A1, WO2019227149A1
WO2017072523A1
(University of Dundee; 4 May 2017; United Kingdom; 28 October 2036)
Lapsed
(A61K31/454, A61P33/02)
None
US10392363B2
(Neoculi Pty Ltd.; 27 August 2019; Australia; 28 August 2035)
Patented case
(A61K31/155, A61K31/381, A61K31/404, A61K31/496, A61K31/505, A61K45/06, A61K9/00, C07C281/18, C07C335/40, C07D209/08, C07D239/50, C07D295/135, C07D333/58, A61K31/17, A61K31/341, A61K31/4045, A61K31/4192, A61K31/44, A61K31/498, C07C211/29, C07C251/24, C07C47/565, C07D209/14, C07D239/48, C07D241/20, C07D249/14, C07D251/54, C07D307/56, C07D311/58, C07D401/14)
AU2015311598A1, AU2020204441B2, BR112017004153A2, CA2959440A1, CN107106524B, EP3188722B1, JP2017528518A, RU2719593C2, RU2020113652A, US10829468B2, US2021009552A1, WO2016033635A1
US10562880B2
(Neoculi Pty Ltd.; 18 February 2020; Australia; 28 August 2035)
US10752606B2
(Neoculi Pty Ltd.; 25 August 2020; Australia; 28 August 2035)
WO2019244049A1
(Novartis; 26 December 2019; USA; 18 June 2039)
National phase entry in many countries
(A61K31/4196, A61K31/4439, A61P33/02, C07D401/14, C07D403/06)
AU2019291490A1, BR112020025538A2, CA3100954A1, CL2020003252A1, CN112313217A, CR20200619A, CU20200102A7, EA202190064A1, ECSP20080991A, EP3810598A1, JOP20200327A1, JP2021528397A, KR20210022646A, MA52977A, PE20210780A1, PH12020552186A1, SG11202012628XA
WO2019043701A1
(Bar-Ilan University; 7 March 2019; USA; 28 August 2038)
Entered into Europe
(A61K31/155, A61K31/7105, A61K33/26, A61K38/00, A61K9/14, B82Y5/00, C01G49/02, C12N15/113)
EP3675875A1
US2021322329A1
(Gador Limitada; 21 October 2021; Chile; 21 August 2038)
Under examination
(A61K31/541, A61K9/51, A61P33/02)
CA3113862A1, EP3842029A1, WO2020037438A1
US2021052498A1
(Northwestern University; 25 February 2021; USA; 29 July 2040)
Under examination
(A61K31/4168, A61K47/34, A61K9/107, A61K9/127, A61P33/02)
None
WO2021123775A2
(JPV01 Ltd.; 24 June 2021; United Kingdom; 16 December 2040)
No national phase entry
(C07K14/705, C07K16/28)
None
US9016221B2
(University of Florida Research Foundation; 28 April 2015; USA;
24 November 2025)
Patented case
(A41D31/00, A61F2/02, A61L2/02, A61L27/00, B08B17/02, B08B17/06, B63B59/04, B64D15/00, A61F2/00, A61F2/12, A61F2/24, B63B1/36
None